GENE ONLINE|News &
Opinion
Blog

2025-11-30|

Researchers Use LSTM Networks to Overcome Free Spectral Range Limitations in Optical Fiber Sensing Systems

by GOAI
Share To

Researchers have developed a new approach that overcomes the limitations of free spectral range (FSR) in interferometric optical fiber sensing systems. The method incorporates Long Short-Term Memory (LSTM) networks, a type of recurrent neural network known for its ability to process and analyze sequential data. This advancement introduces significant improvements in the field of optical fiber sensing technology by addressing constraints that have long restricted system performance.

The integration of LSTM networks enables enhanced data interpretation within interferometric systems, which traditionally face challenges due to FSR limitations. Optical fiber sensors rely on interference patterns to measure various physical parameters, but their accuracy and range are often constrained by the spectral limits inherent in these systems. By utilizing LSTM networks, researchers can effectively process complex sequences of data, allowing for more precise measurements and expanded operational capabilities beyond previous boundaries. This development marks a notable step forward in advancing optical sensing technologies.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 1, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top